	Statins
Secondary prevention
Angiotensin receptor blockers
Beta-blockers
Angiotensin converting enzyme inhibitors
Myocardial infarction
	ACE inhibitor
acute MI
copayment
years
days
statin use
BBs
BB use
MI admission
medications
non-acute care hospital
patients
prescription
discharge
indicator drugs
admission
health care system
study
lower use
secondary prevention
population
sickness funds
hospitals
fewer
Age
ARBs
study drug use
Maximizing secondary prevention
statins
reports
lower
absolute contraindications
aspirin
care
interventions
individuals
full multivariate models
odds
similar
results not
ascertained

